https://pubmed.ncbi.nlm.nih.gov/21512265/
Oral administration of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) improves the survival...
To investigate the usefulness of the immunopotentiator from Pantoea agglomerans 1 (IP-PA1) as a supportive drug in melanoma therapy, we analyzed the...